MindBio Therapeutics CEO Discusses AI Voice Detection Platform for Workplace Intoxication Screening on TechMediaWire Podcast

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka recently joined the TechMediaWire Podcast to discuss the company's artificial intelligence-driven voice analysis technology, which aims to detect drug and alcohol intoxication through noninvasive speech analysis. The interview highlighted the limitations of traditional testing methods and outlined MindBio's commercial focus on regulated workplace environments, particularly the mining industry, where the company believes its scalable detection platform could enhance safety by expanding real-time intoxication screening capabilities.

According to Hanka, traditional methods such as breathalyzers and urine tests are often invasive, time-consuming, and not suitable for continuous monitoring. In contrast, MindBio's AI prediction model leverages over 50 million data points to predict alcohol intoxication with remarkable accuracy using only the human voice. This technology is being developed into an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software, designed for deployment in a range of enterprise environments, including mining, aviation, construction, and law enforcement.

The implications of this announcement are significant for workplace safety. In industries where impairment due to drugs or alcohol can lead to catastrophic accidents, having a noninvasive, real-time screening tool could revolutionize safety protocols. The mining sector, for instance, often operates in remote locations where traditional testing is logistically challenging. MindBio's voice analysis technology could allow for frequent, unobtrusive checks, potentially reducing the risk of incidents caused by impaired workers.

Moreover, the scalability of the platform suggests that it could be adapted for other high-risk environments, such as aviation and construction, where even brief periods of impairment can have severe consequences. The company's focus on regulated workplaces indicates a strategic approach to commercialization, targeting sectors where regulatory compliance and safety are paramount.

For more details, the full press release can be viewed at https://ibn.fm/SU3Ay. Additional information and updates regarding MBQIF are available in the company's newsroom at https://ibn.fm/MBQIF.